|Bid||1.58 x 2200|
|Ask||0.00 x 1000|
|Day's range||6.69 - 7.35|
|52-week range||5.70 - 11.90|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||N/A|
|Earnings date||29 Jun 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.75|
Actinium (ATNM) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Actinium Pharmaceuticals (ATNM) closed the most recent trading day at $11.22, moving +0.9% from the previous trading session.